SEC Form 4/A · accession 0001250853-16-000170
IOVANCE BIOTHERAPEUTICS, INC. · IOVA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
This is an amendment (Form 4/A). It replaces an earlier filing for the same period.
Reporting owner
Iain D. Dukes
Director
Period of report
Aug 16, 2016
Accepted (ET)
Aug 19, 2016 · 7:21 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001425205
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1,F2 | $9.10 | Aug 16, 2016 | A | 70,000 | A | — | Aug 15, 2026 | Common Stock | 70,000 | 70,000 | D |
Explanation of responses
- F1On August 16, 2016, the Company granted options to purchase 35,000 shares to its non-executive directors. Dr. Iain Dukes, the reporting person, is a non-executive director and thus received options to purchase 35,000 shares. In addition, Dr. Dukes received options to purchase an additional 35,000 shares for being Chairman of the Company's board of directors, for a total option grant of 70,000 shares. The option to purchase the additional 35,000 shares was omitted from the reporting person's original Form 4, filed on August 18, 2016, and are accordingly being disclosed in this amendment.
- F2These options are exercisable in four equal quarterly installments of 17,500 each following the date of grant. If the reporting person's service to the Issuer terminates before the expiration date, the option shares will be exercisable for two years following termination of service unless the Reporting Person is terminated for cause, in which case the options are terminated.